MAPT and amyotrophic lateral sclerosis: In up to 97% of ALS cases and the majority of non-tau-related FTLD cases, these aggregates contain the human nuclear ribonuclear protein TAR DNA-binding protein 43 (TDP-43), suggesting similar molecular mechanisms for the two diseases [9,10,11].